Teyi Pharmaceutical Group Co Ltd (002728) — Cash Flow-to-Debt Ratio
Teyi Pharmaceutical Group Co Ltd (002728) has a Cash Flow-to-Debt Ratio of 0.11x as of December 2025, meaning its operating cash flow of CN¥52.94 Million could theoretically repay 0% of its total liabilities (CN¥472.69 Million) in one year. See free cash flow generation of Teyi Pharmaceutical Group Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Teyi Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Teyi Pharmaceutical Group Co Ltd across 17 annual periods. Also explore 002728 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Teyi Pharmaceutical Group Co Ltd (2009–2025)
Year-by-year debt coverage analysis for Teyi Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see 002728 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.52x | CN¥244.88 Million | CN¥472.69 Million | ▲ +1561.0% |
| 2024 | -0.04x | CN¥-22.55 Million | CN¥635.94 Million | ▼ -109.0% |
| 2023 | 0.40x | CN¥198.56 Million | CN¥501.95 Million | ▲ +21.6% |
| 2022 | 0.33x | CN¥371.66 Million | CN¥1.14 Billion | ▲ +1.9% |
| 2021 | 0.32x | CN¥256.81 Million | CN¥804.51 Million | ▲ +122.1% |
| 2020 | 0.14x | CN¥168.99 Million | CN¥1.18 Billion | ▼ -28.4% |
| 2019 | 0.20x | CN¥221.64 Million | CN¥1.10 Billion | ▲ +2.2% |
| 2018 | 0.20x | CN¥187.97 Million | CN¥956.39 Million | ▲ +69.2% |
| 2017 | 0.12x | CN¥102.96 Million | CN¥886.14 Million | ▼ -17.8% |
| 2016 | 0.14x | CN¥101.30 Million | CN¥716.61 Million | ▲ +62.9% |
| 2015 | 0.09x | CN¥68.87 Million | CN¥793.78 Million | ▼ -86.4% |
| 2014 | 0.64x | CN¥57.35 Million | CN¥89.96 Million | ▼ -11.2% |
| 2013 | 0.72x | CN¥74.23 Million | CN¥103.40 Million | ▼ -29.3% |
| 2012 | 1.02x | CN¥104.50 Million | CN¥102.88 Million | ▼ -16.0% |
| 2011 | 1.21x | CN¥69.81 Million | CN¥57.71 Million | ▲ +111.2% |
| 2010 | 0.57x | CN¥46.92 Million | CN¥81.92 Million | ▲ +121.9% |
| 2009 | 0.26x | CN¥22.32 Million | CN¥86.47 Million | — |